OverviewSuggest Edit
Cytori Therapeutics develops cellular therapeutics for specific diseases and medical conditions. The Company primarily provides Cytori Cell Therapy for the treatment of impaired hand function in scleroderma. It also offers Celution System devices, proprietary enzymes, and sterile consumable sets, and StemSource cell and tissue banking systems, as well as surgical accessories and instruments. The Company also provides a number of products for use in treating various cancers.
| Type | Public | |
| Founded | 2002 | |
| HQ | San Diego, US | Map |
| Website | cytori.com | |
| Employee Ratings | More |
Key People/Management at Cytori Therapeutics
John K. Fraser
Marc H. Hedrick
Gregg A Lapointe
Gary A. Lyons
Ronald A. Martell
Richard J. Hawkins
Cytori Therapeutics Office Locations
Cytori Therapeutics Financials and Metrics
Cytori Therapeutics Revenue
| USD | |
|---|---|
Net income (Q3, 2018) | (2.3m) |
EBIT (Q3, 2018) | (1.5m) |
Market capitalization (16-Aug-2018) | 194.3k |
Closing stock price (16-Aug-2018) | 0.3 |
Cash (30-Sep-2018) | 6.8m |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|
Revenue | 7.1m | 5.0m | 4.8m | 4.7m | |
Revenue growth, % | (30%) | (2%) | (4%) | ||
Cost of goods sold | 3.4m | 2.9m | 3.2m | 2.7m | |
Gross profit | 3.7m | 2.0m | 1.7m | 1.9m |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales and marketing expense | 1.8m | 1.9m | 1.9m | 1.5m | 654.0k | 566.0k | 1.0m | 889.0k | 818.0k | 939.0k | 1.3m | 840.0k | 678.0k | 525.0k | 453.0k |
General and administrative expense | 4.3m | 4.3m | 4.6m | 4.2m | 2.8m | 2.4m | 2.3m | 2.3m | 2.0m | 2.1m | 2.1m | 1.8m | 2.2m | 1.5m | 1.5m |
R&D expense | 4.1m | 4.3m | 4.7m | 3.1m | 6.0m | 4.4m | 4.1m | 5.2m | 4.0m | 3.3m | 3.0m | 3.0m | 2.5m | 2.0m | 1.9m |
Operating expense total | 10.2m | 10.6m | 11.2m | 8.7m | (3.6m) | (22.0k) | 7.4m | 8.5m | 6.8m | 8.0m | 6.4m | 5.6m | 5.4m | 3.9m | 2.2m |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 10.2m | 12.8m | 12.8m | 7.8m | 23.8m | 19.0m | 9.4m | 20.0m | 14.9m | 6.3m | 9.0m | 4.8m | 5.9m | 3.1m | 6.8m |
Inventories | 4.1m | 4.2m | 4.5m | 5.0m | 4.1m | 4.6m | 4.5m | 4.5m | 3.9m | 4.1m | 4.2m | 3.5m | 3.2m | 3.0m | 2.8m |
Current Assets | 18.1m | 22.1m | 20.5m | 14.6m | 29.7m | 26.0m | 16.5m | 26.8m | 21.0m | 12.1m | 15.6m | 9.8m | 10.7m | 7.4m | 10.8m |
PP&E | 1.2m | 1.3m | 1.6m | 1.9m | 1.7m | 1.5m | 1.4m | 1.3m | 3.6m | 3.4m | 3.3m | 2.9m | 2.8m | 2.6m |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (16.1m) | (10.4m) | (22.2m) | (31.6m) | (17.5m) | (16.0m) | (5.3m) | (11.7m) | (17.1m) | (7.5m) | (13.6m) | (18.4m) | (4.4m) | (8.1m) | (10.4m) |
Depreciation and Amortization | 1.2m | 160.0k | 344.0k | 525.0k | 510.0k | 761.0k | 291.0k | 574.0k | 794.0k | 442.0k | 1.1m | 1.6m | 497.0k | 975.0k | 1.5m |
Inventories | (975.0k) | (551.0k) | (526.0k) | (1.2m) | 730.0k | (10.0k) | (206.0k) | (380.0k) | 190.0k | 7.0k | 159.0k | 457.0k | 141.0k | 371.0k | 615.0k |
Accounts Payable | (1.1m) | 351.0k | 124.0k | (666.0k) | 1.1m | 870.0k | 176.0k | (431.0k) | (1.0m) | (484.0k) | (194.0k) | (1.7m) | (556.0k) | (1.2m) | (1.3m) |
| USD | Y, 2018 |
|---|---|
Financial Leverage | 4.2 x |
Cytori Therapeutics Online and Social Media Presence
2.29k Twitter followers
Cytori Therapeutics has 2.29k Twitter Followers. The number of followers has decreased 0.3% quarter over quarter
Twitter Engagement Stats for @Cytori
2.2k
Tweets
1.5k
Following
2.3k
Followers
1
Tweets last 30Â days
0
Avg. likes per Tweet
0%
Tweets with engagement
Cytori Therapeutics News and Updates
Cytori Therapeutics Announces Receipt of Puregraft® Royalty Milestone
Cytori Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
 Cytori Therapeutics Frequently Asked Questions
When was Cytori Therapeutics founded?
Cytori Therapeutics was founded in 2002.
Who are Cytori Therapeutics key executives?
Cytori Therapeutics's key executives are John K. Fraser, Marc H. Hedrick and Gregg A Lapointe.
How many employees does Cytori Therapeutics have?
Cytori Therapeutics has 80 employees.
Who are Cytori Therapeutics competitors?
Competitors of Cytori Therapeutics include CollPlant , MolMed and ImmunoCellular Therapeutics.
Where is Cytori Therapeutics headquarters?
Cytori Therapeutics headquarters is located at 3020 Callan Rd, San Diego.
Where are Cytori Therapeutics offices?
Cytori Therapeutics has offices in San Diego, San Antonio, Deeside and Tokyo.
How many offices does Cytori Therapeutics have?
Cytori Therapeutics has 4 offices.